SCHEMBL2503229

SCHEMBL2503229

CCC[C@@H](c1cccc(OCc2ccc(-c3cc(OC)ccc3F)c(OC3CCCCO3)c2)c1)C(C)C(=O)O

nearest known ligand 0.53

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
FFAR1 O14842 20/20 0.53

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2501633 1.00 FFAR1 (0.53) FFAR1
SCHEMBL2504449 0.91 FFAR1 (0.55) FFAR1
SCHEMBL2501787 0.91 FFAR1 (0.55) FFAR1
SCHEMBL2506126 0.88 FFAR1 (0.68) FFAR1
SCHEMBL12195079 0.88 FFAR1 (0.68) FFAR1
SCHEMBL12195076 0.88 FFAR1 (0.68) FFAR1
SCHEMBL2500978 0.88 FFAR1 (0.68) FFAR1
SCHEMBL12194468 0.87 FFAR1 (0.67) FFAR1
SCHEMBL12194467 0.87 FFAR1 (0.67) FFAR1
SCHEMBL2498816 0.87 FFAR1 (0.67) FFAR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8030354-B2 2-(5,5-Dimethylcyclopent-1-enyl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane; metabolic disorders such as type II diabetes AMGEN INC. (US) 2011-10-04 US disclosed